Progress of fundamental research in Wilms' tumor

Urological Research

Volumn 25, Issue 4, 1997, Pages 223-230

  Wen, J G ^a   Van Steenbrugge, G J ^a   Egeler, R M ^b   Nijman, R M ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Experimental model; Growth factors; Histopathology; Tumor markers; Wilms' tumor

Indexed keywords

ACTIVIN; CYCLINE; CYTOKERATIN; DESMIN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; MIDKINE; NEUROTROPHIN RECEPTOR; PLATELET DERIVED GROWTH FACTOR A; PROTEIN P53; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TENASCIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 11P; CHROMOSOME 16Q; CYTOGENETICS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMEDIATE FILAMENT; MOUSE; NEPHROBLASTOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 0030882445     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00942090     Document Type: Article

References (94)

1. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Rutledge JC (1995) Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney Int 48:146
2. Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z, Cordon-Cardo C (1994) Immunohistochemical determination of p53 protein nuclear accumulation in prostate adenocarcinomas. J Urol 151:1276
3. Baker ST, Fearan ER, Nigro JM (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinoma. Science 244:217
4. Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J (1994) Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7:91
5. Bardeesy N, Beckwith B, Pelletier J (1995) Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 55:215
6. Beckwith JB (1983) Wilms' tumor and other renal tumors of childhood: A selective review from the National Wilms' Tumor Study Pathology Center Human Pathol 14:482
7. Beckwith JB (1988) Pathological aspects of renal tumors in childhood. In. Broecker BH, Klein FA (eds) Pediatric tumors of the genitourinary tract. Alan R Liss, New York, p 25
8. Beckwith JB (1994) Renal tumors in the pediatric patient. In: Tisher CC. Brenner BM (eds) Renal pathology With clinical and functional correlations. 2nd edn, J B Lippincott, Philadelphia, p 1513
9. Beckwith JB, Kiviat NB, Bonadio JF (1990) Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms tumor. Pediatr Pathol 10:1
10. Beierle JW, Heimerl DM, Allerton SE, Bavetta LA (1971) Growth promotion by extracts from Wilms' tumor in vitro. Experientia 27:435
11. Bonadio JF, Storer B, ,Norkool P, Farewell VT, Beckwith JB, D'Angio GJ (1985) Anaplastic Wilms' tumor: clinical and pathologic studies. J Clin Oncol 3:513
12. Chang F, Syrjanen S, Kururen K, Syrjanen K (1993) The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 88:174
13. Cheah PL, Looi LM, Chan LL (1996) Immunohistochemical expression of p53 proteins in Wilms' tumor: a possible association with the histological prognostic parameter of anaplasia. Histopathology 28:49
14. Clarke AR (1995) Murine models of neoplasia: functional analysis of the tumor suppressor genes Rb-1 and p53. Cancer Metastasis Rev 14:125
15. Clemmons DR (1992) IGF binding proteins: regulators of cellular actions. Growth Regul 2:80
16. D'Angio GJ, Evans AE, Breslow NE, Sharles K (1989) The treatment of Wilms' tumor, results of the Third National Wilms' Study. Cancer 64:349
17. Delahunt B, Farrant GJ, Bethwaite PB, Nacey JN, Lewis ME (1994) Assessment of proliferative activity in Wilms' tumor. Anal Cell Pathol 7:127
18. Donovan MJ, Hempstead B, Huber LJ, Kaplan D, Tsoulfas P, Chao M, Parada L, Schofield D (1994) Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors. Am J Pathol 145:792
19. Dowdy SF, Weissman BE, Stanbridge EJ (1991) Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma. J Cell Physiol 147:248
20. Drop SLS, Schuller AGP, Lindenbergh-Kortleve DJ, Groffen C, Brinkman A, Zwarthoff EC (1992) Structural aspects of the IGFBP family. Growth Reg 2:60
21. Droz D, Rousseau-Merck MF, Jaubert F, Diebold N, Nezelof C, Adafer E, Mouly H (1990) Cell differentiation in Wilms' tumor (nephroblastoma): an immunohistochemical study. Hum Pathol 21:536
22. Durbeej M, Soderstrom S, Ebendal T, Birchmeier, Ekblom P (1993) Differential expression of neurotrophin receptors during renal development. Development 119:977
23. Fearon ER, Vogelstein B, Feinberg AP (1984) Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours. Nature 309:176
24. Fraizer GE, Bowen-Pope DF, Vogel AM (1987) Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells. J Cell Physiol 133:169
25. Gansler T, Allen KD, Inabnett T, Scptt A, Buse MG, Sens DA, Gervin AJ (1988) Detection of type-I insulin-like growth factor (IGF) receptor in Wilms' tumors. Am J Patholol 130:431
26. Gansler T, Furlanetto R, Gramoing TS, Robinson KA, Btocker N, Buse MG, Sens DA, Garvin AJ (1989) Antibody to type I insulin-like growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic nude mice. Am J Pathol 135:961
27. Garvin AJ, Surrette F, Hintz DS, Rudisill MT, Sens MA, Sens DA (1985) The in vitro growth and characterization of the skeletal component of Wilms' tumor. Am J Pathol 121:298
28. Garvin AJ, Sollivan JL, Bennett DD, Stanley WS, Inanmett T, Sens DA (1987) The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastema component of Wilms' tumor. Am J Pathol 129:353
29. Garvin AJ, Congleton L, Inabnett T, Gansler T, Sens DA (1988) Growth characteristics of human Wilms' tumor in nude mice. Pediatr Pathol 8:599
30. Garvin AJ, Gansler T, Gerald W, Sens DA (1991) Insulin-like growth factor production by childhood solid tumors. Perspect Pediatr Pathol 15.106
31. Gerald WL, Stokes Gramlig T, Sens DA (1992) Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor. Am J Pathol 140:1031
32. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad H(1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody K.i-67. Am J Pathol 138:867
33. Goebel HH (1995) Desmin-related neuromuscular disorders. Muscle Nerve 18:1306
34. Goustin AS, Leof EB, Sjipley GD (1986) Growth factors and cancer. Cancer Res 46:1015
35. Groot-Loonen JJ, Pinkerton CR, Morris-Jones PH (1990) Howcurable is relapsed Wilms' tumor? Arch Dis Child 65:968
36. Grown AM, Leong AS (1993) Immunohistochemistry of 'solid' tumors: poorly differentiated round cell and spindle cell tumors II. In: Leong AS (ed) Applied immunohistochemistry for the surgical pathologist. Edward Arnold, London, p 73
37. Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK (1988) Familial predisposition to Wilms' tumor does not map to the short arm of chromosome 11. Nature 336:374
38. Hammerman MR (1995) Growth factors in renal development. Semin Nephrol 15:291
39. Hazen-Martin DJ, Garvin AJ, Gansler T, Tarnowski BI, Sens DA (1993) Morphology and growth characteristics of epithelial cells from classic Wilms' tumors. Am J Pathol 142:893
40. Hennigar RA, Beckwith JB (1992) Nephrogenic adenofibroma. A novel kidney tumor of young people. Am J Surg Pathol 16:325
41. Hirschfeld S, Helman L (1994) Diverse roles of insulin-like growth factors in pediatric solid tumors. In Vivo 8:81
42. Hou LT, Holman RL (1996) Bilateral nephroblastomatosis in a premature infant. J Pathol 82:249
43. Huff V, Compton DA, Chao LY, Strong LC, Geiser CF, Saunders GF (1988) Lack of linkage of familial Wilms' tumor to chromosomal band 11 p13. Nature 336:377
44. Ishiwata I, Ono I, Ishiwata C, Nakaguchi T, Ohara K, Hirano M, Ishikawa H (1991) Carcinoembryonic proteins produced by Wilms' tumor cells in vitro and in vivo. Exp Pathol 41:1
45. Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, Van Velzen D (1994) Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Lab Invest 70:125
46. Lahoti C, Thorner P, Malkin D, Yeger H (1996) Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. Am J Path 148:1577
47. Leape LL, Breslow NE, Bishop HC (1978) The surgical treatment of Wilms' tumor results of the National Wilms' Tumor Study. Ann Surg 187:351
48. Lee JM, Bernstein A (1995) Apoptosis, cancer and the p53 tumor suppressor gene. Cancer Metastasis Rev 14:149
49. Leeuwen EH van, Postma A, Oosterhuis JW, Meiring A, Counelisse CJ, Koudstaal J, Molemaar WM (1987) An analysis of histology and DNS-ploidy in primary Wilms' tumors and their metastases and a study of the morphological effects of therapy. Virchows Arch A 410:487
50. Lemerle J, Tournade M, Habrand L (1989) The treatment of Wilms' tumor: An update. In: Murph GP, Khoury S (eds) Therapeutic progress in prological cancers. Alan R Liss, New York, p 629
51. Lemoine NR, Hughes CM, Cowell JK (1992) Aberrant expression of the tumor suppressor gene p53 is very frequent in Wilms' tumors. J Pathol 168:237
52. Looi LM, Cheah PL (1993) An immunohistochemical study comparing clear cell sarcoma of the kidney and Wilms' tumor. Pathology 25 106
53. Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, de Pagter-Holthuizen P, Pearson PL (1988) Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 81:41
54. Matsunaga E (1981) Genetics of Wilms' tumor. Hum Genet 57:231
55. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE (1992) A third Wilms' tumor locus on chromosome 16q. Cancer Res 52:3094
56. Mesfin GM, Breech KT (1996) Heritable nephroblastoma (Wilms' tumor) in the Upjohn Sprague Dawley rat. Lab Animal Sci 46:321
57. Mesrobian HGJ (1988) Wilms tumor: past, present, future. J Urol 140:231
58. Miwa H, Tomlinson GE, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF (1992) RNA expression of the WT1 gene in Wilms' tumors in relation to histology. J Natl Cancer Inst 84.181
59. Nagoshi M, Tsuneyoshi M (1994) Expression of proliferating cell nuclear antigen in Wilms' tumors and other pediatric renal tumors: the correlation between histologic classification and proliferative activity. J Surg Oncol 55:114
60. Neely JE, Ballard ET, Britt AF, Workman L (1993) Characteristics of 85 pediatric heterotransplants into nude mice. Expl Cell Biol 51:217
61. Paik S, Rosen N, Jung W, You JM, Lippman ME, Perdue JF, Yee D (1989) Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study. Lab Invest 61:522
62. Parham DM (1993) Immunohistochemistry of childhood sarcomas: Old and new markers. Mod Pathol 6:133
63. Pritchard-Jones K, Hastie N (1990) Wilms' tumor as a paradigm for the relationship of cancer to development. Cancer Surv 9:555
64. Pritchard-Jones K, Fleming S (1991) Cell types expressing the Wilms' tumor gene (WT1) in Wilms' tumors; implications for tumor histogenesis. Oncogene 6:2211
65. Re GG, Hazen-Martin DJ, Sens DA, Julian Garvin A (1994) Nephroblastoma (Wilms' tumor): A model system of aberrant renal development. Semin Diagn Pathol 11:126
66. Reeve AE, Eccles MR, Wilkins RJ, Bell GL Millow LJ (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumor. Nature. 317:258
67. Reeve AE, Sih SA, Raizis AM, Feinberg AP (1989) Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol 9:1799
68. Ren-Qiu Q, Ruelicke T, Hassam S, Haselbacher GK, Schoenle EJ (1993) Systemic effects of insulin-like growth factor-II produced and released from Wilms tumor tissue. Eur J Pediatr 152:102
69. Ren-Qiu Q, Schmitt S, Ruelicke T, Stallmach T, Schoenle EJ (1996) Autocrine regulation of growth by insulin-like growth factor (IGF)-II mediated by type I IGF-receptor in Wilms tumor cells. Pediatr Res 39:160
70. Roald B, Brandtzaeg P (1991) Immunohistochemistry on needle biopsies of childhood malisnancies. Pathol Res Pract 187:917
71. Rutna EM, Pekonen F, Makinen T (1988) Soluble 34 K binding proteins inhibit the binding of insulin-like growth factor I to its own receptors in human secretory phase endometrium: Evidence for autocrine, paracrine regulation of growth factor action. J Clin Endocrinol Met 66:173
72. Sarawar SR, Schlingemann RO, Kelsey A, Fleming S, Kumar S (1988) A monoclonal antibody stains blastemal but not tubular components of Wilms' tumor. J Pathol 156:319
73. Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rail LB, Graham CF (1985) Insulin-like growth factor-II gene expression in Wilms' tumor and embryonic tissues. Nature 317:260
74. Shimosato Y, Kameya T, Nagia K, Hirohashi S, Koide T, Nomura T, Hayashi H (1976) Transplantation of human tumors in nude mice. J Natl Cancer Inst 56:1251
75. Siles E, Villalobos M, Valenzuela MT, Nunez MI, Gordon A, Memillan TJ, Pedraza V, Dealmodovar JMR (1996) Relationship between p53 status and radiosensitivity in human tumor cell lines. Br J Cancer 73:581
76. Slater RM, Mannens MMA (1992) Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogenet 61.111
77. Sola JE, Wojno KJ, Dooley W, Colombani PM (1994) P-glycoprotein status of favorable-histology Wilms' tumor predicts treatment outcome. J Pediatr Surg 29:1080
78. Steenbrugge GJ van, Boijmans AP Ton, Hollander JC den, Jong FH de. Nijman JM Rien (1995) Human Wilms' tumor models in nude mice: properties, in vitro growth and expression of activin receptors. Urol Res 23:262
79. Stone CH, Lynch EF, Linden MD, Kubus JJ, Zarbo RJ (1996) Immunocytochemical evaluation of proliferating cell nuclear antigen, ki-67 (MIB-1). and p53 in predicting survival of primary and metastatic malignant melanomas. Appl Immunohistochem 4:25
80. Sumino K, Nagashima Y, Ohaki Y, Umeda M (1992) Isolation of subclones with different tumorigenicity and metastatic ability from rat nephroblastoma cell line, ENUT. Acta Pathologica Japonica 42:166
81. Takeuchi S, Bartram CR, Ludwig R, Royer-Pokora B, Schneider S, Imamura J, Koeffler HP (1995) Mutations of p53 in Wilms' tumors. Mod Pathol 8:483
82. Talts JF, Aufderheide E, Sorokin L, Ocklind G, Mattsson R, Ekblom P (1993) Induction of mouse tenascin expression by a human sarcomatoid Wilms' tumor cell line growing in nude mice. Int J Cancer 54:868
83. Tarnowski BI, Hazin-Martin DJ, Garvin AJ, Sens MA (1994) Characterization of a monoclonal antibody recognizing the blastemal element of Wilms' tumors and fetal kidneys. Pediatr Pathol 14:849
84. Tessarollo L, Tsoulfas P, Martin-Zanca D, Gilbert D, Jenkins N, Copeland N, Parada L (1993) Trk C, a receptor for meurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues. Development 118:463
85. Thomson TM, Pellicer A, Greene LA (1989) Functional receptors for nerve growth factor on Ewing's sarcoma and Wilm's tumor cells. J Cell Physiol 141:60
86. Tomomura M, Kadomatsu K, Matsubara S, Muramatsu T (1990) A retinoic acid-responsive gene, MK, found in the teratocarcmoma system. Heterogeneity of the transcript and the nature of the translation-product. J Biol Chem 265: 10765
87. Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, Shimazu H, Ohi Y, Muramatsu T (1993) A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res 53:1281
88. Waber PG, Jun Chen MLS, Nisen PD (1993) Infrequency of ras, p53. WT1, of RB gene alterations in Wilms tumors. Cancer 72:3732
89. Weerden WM van, Ridder CMA de, Verdaasdonk CL, Romijn JC, Kwast TH van der, Schröder FI, Steenbrugge GJ van (1996) Seven newly developed human prostate tumor xenograft models: establishment and histopatholoaical characterization. Am J Pathol 149:1055
90. Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ (1987) Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236:175
91. Wiliams JA, Douglass EC, Hammond E (1985) Relapsed Wilms' tumor, factors affecting survival and cure. Am J Clin Oncol (CCT) 8:324
92. Wilms M (1889) Die Mischgeschwuelste der Niere. Arthur Georgi, Leipzig, p 1
93. Yeger H, Baumal R, Pawlin G, Phillips MJ (1985) Relationship of histology of Wilms' tumor to growth characteristics of nude mouse heterotransplants Cancer Res 45:2340
94. Yoshryuki T, Shimizu Y, Onda M, Tokunaga A, Kiyama T, Nishi K, Mizutani T, Matsukura N, Tanaka N, Akimoto M, Asano G (1989) Immunohistochemical demonstration of epidermal growth factor in human gastric cancer xenograft of nude mice Cancer 65:953